Electra Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ETRA | ATRA | ZVRA | PBYI | AVBP | ABEO | |
|---|---|---|---|---|---|---|
| Market cap | 500.25M | 84.02M | 663.32M | 551.82M | 665.16M | 241.32M |
| P/E (TTM) | — | — | 9.2 | 21.0 | — | — |
| Forward P/E | -4.4 | 5.4 | 10.4 | 30.5 | -3.6 | -20.3 |
| Price/book | 0.0 | -2.1 | 2.8 | 3.9 | 1.8 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −39.09% | −23.72% | +22.88% | +118.16% | −26.64% | +0.72% |
| Today | −1.24% | +2.07% | +8.87% | +4.60% | +3.61% | −0.71% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ETRA news ›Atara Biotherapeutics (ATRA) Expected to Announce Earnings on Wednesday
Posted by Kim Johansen on Nov 4th, 2026 NASDAQ:ATRA opened at $8.25 on Wednesday. The company has a market cap of $82.83 million, a price-to-earnings ratio of -6.99 and a beta of 0.28. Atara Biotherapeutics has a twelve month low of $3.92…
Ecora Resources (LON:ECOR) Stock Rating Reaffirmed as Buy by Berenberg Bank
Posted by Danessa Lincoln on Oct 24th, 2026 Ecora Resources (LON:ECOR – Get Free Report)‘s stock had its “buy” rating reissued by Berenberg Bank in a report issued on Wednesday, Digital Look reports. They currently have a GBX 180 target…
Electra Therapeutics, Inc.’s Quiet Period Set To End on October 28th (NASDAQ:ETRA)
Posted by Mitch Edgeman on Oct 23rd, 2026 Check Out Our Latest Stock Analysis on Electra Therapeutics NASDAQ:ETRA opened at $9.25 on Friday. Electra Therapeutics has a 52 week low of $8.50 and a 52 week high of $15.50. Electra Therapeutics…
More from 1 other outlet
Legora hits $8.8bn valuation in Series E funding round
Legora has raised an additional $550m at an $8.8bn valuation to help fuel the Swedish legal tech’s rapid growth ambitions. The Series E funding round was led by Atreides Management… Legora hits $8.8bn valuation in Series E funding round…
Electra Therapeutics, Inc. (NASDAQ:ETRA) Stock Has Average Target Price of $34.00
Electra Therapeutics, Inc. (NASDAQ:ETRA – Get Free Report) has earned an average rating of “Buy” from the five ratings firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating,…
Jefferies Financial Group Upgrades Electra Therapeutics (NASDAQ:ETRA) to "Strong-Buy"
Electra Therapeutics (NASDAQ:ETRA - Get Free Report) was upgraded by research analysts at Jefferies Financial Group to a "strong-buy" rating in a research note issued on Tuesday, Zacks reports. Check Out Our Latest Report on Electra…
Free float of Electra Therapeutics, Inc. – BOATS:ETRA
TradingView Free float of Electra Therapeutics, Inc.
Electra Therapeutics (NASDAQ:ETRA) Stock Picked Up by Analysts at JPMorgan Chase & Co.
Posted by Tristan Rich on Oct 22nd, 2026 Research analysts at JPMorgan Chase & Co. began coverage on shares of Electra Therapeutics (NASDAQ:ETRA – Get Free Report) in a research report issued to clients and investors on Thursday,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com6
- marketbeat.com3
- defenseworld.net1
- thelawyer.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.